A detailed history of Sage Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sage Advisors, LLC holds 18,677 shares of LLY stock, worth $14 Million. This represents 13.03% of its overall portfolio holdings.

Number of Shares
18,677
Previous 18,652 0.13%
Holding current value
$14 Million
Previous $16.9 Billion 2.02%
% of portfolio
13.03%
Previous 13.73%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $19,303 - $24,000
25 Added 0.13%
18,677 $16.5 Billion
Q2 2024

Sep 27, 2024

BUY
$724.87 - $909.04 $133,376 - $167,263
184 Added 1.0%
18,652 $16.9 Billion
Q1 2024

Sep 27, 2024

BUY
$592.2 - $792.28 $1.8 Million - $2.41 Million
3,046 Added 19.75%
18,468 $14.4 Billion
Q4 2023

Sep 20, 2024

BUY
$525.19 - $619.13 $8.1 Million - $9.55 Million
15,422 New
15,422 $8.99 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sage Advisors, LLC Portfolio

Follow Sage Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Advisors, LLC with notifications on news.